
Laura Lynne Stockton
Examiner (ID: 15659, Phone: (571)272-0710 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1201, 2899, 1626, 1613, 1614, 1646 |
| Total Applications | 3283 |
| Issued Applications | 2225 |
| Pending Applications | 331 |
| Abandoned Applications | 760 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5821101
[patent_doc_number] => 20060025414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-02
[patent_title] => 'Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists'
[patent_app_type] => utility
[patent_app_number] => 11/060561
[patent_app_country] => US
[patent_app_date] => 2005-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28915
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20060025414.pdf
[firstpage_image] =>[orig_patent_app_number] => 11060561
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/060561 | Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists | Feb 17, 2005 | Abandoned |
Array
(
[id] => 5189196
[patent_doc_number] => 20070167505
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Substituted benzimidazoles and their use for inducing apoptosis'
[patent_app_type] => utility
[patent_app_number] => 10/587675
[patent_app_country] => US
[patent_app_date] => 2005-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14565
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167505.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587675
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587675 | Substituted benzimidazoles and their use for inducing apoptosis | Feb 9, 2005 | Abandoned |
Array
(
[id] => 4989464
[patent_doc_number] => 20070155805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-05
[patent_title] => 'Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease'
[patent_app_type] => utility
[patent_app_number] => 10/597870
[patent_app_country] => US
[patent_app_date] => 2005-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48282
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20070155805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10597870
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/597870 | Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease | Feb 9, 2005 | Abandoned |
Array
(
[id] => 7111828
[patent_doc_number] => 20050209284
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Tec kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/055798
[patent_app_country] => US
[patent_app_date] => 2005-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31040
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20050209284.pdf
[firstpage_image] =>[orig_patent_app_number] => 11055798
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/055798 | Tec kinase inhibitors | Feb 8, 2005 | Abandoned |
| 11/053686 | Amides of antibiotic GE 2270 factors | Feb 6, 2005 | Abandoned |
Array
(
[id] => 6997777
[patent_doc_number] => 20050137406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines'
[patent_app_type] => utility
[patent_app_number] => 11/051706
[patent_app_country] => US
[patent_app_date] => 2005-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9492
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11051706
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/051706 | Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive of levulinic acid esters with aryl and alkyl amines | Feb 3, 2005 | Issued |
Array
(
[id] => 6926596
[patent_doc_number] => 20050239853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-27
[patent_title] => 'New compounds'
[patent_app_type] => utility
[patent_app_number] => 11/050178
[patent_app_country] => US
[patent_app_date] => 2005-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65882
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0239/20050239853.pdf
[firstpage_image] =>[orig_patent_app_number] => 11050178
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/050178 | New compounds | Feb 2, 2005 | Abandoned |
Array
(
[id] => 6913207
[patent_doc_number] => 20050176965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/049815
[patent_app_country] => US
[patent_app_date] => 2005-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11121
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176965.pdf
[firstpage_image] =>[orig_patent_app_number] => 11049815
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/049815 | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors | Feb 2, 2005 | Issued |
| 11/049506 | AMINOALKYLPHENYL INDOLONE DERIVATIVES | Feb 1, 2005 | Abandoned |
Array
(
[id] => 4652210
[patent_doc_number] => 20080039466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-14
[patent_title] => '2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/587436
[patent_app_country] => US
[patent_app_date] => 2005-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16145
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20080039466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10587436
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/587436 | 2-(3-Substituted-Aryl) Amino-4-Aryl-Thiazoles As Tyrosine Kinase Inhibitors | Jan 27, 2005 | Abandoned |
Array
(
[id] => 401271
[patent_doc_number] => 07291636
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-06
[patent_title] => 'Acylaminothiazole derivatives, preparation and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/035803
[patent_app_country] => US
[patent_app_date] => 2005-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33244
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/291/07291636.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035803
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035803 | Acylaminothiazole derivatives, preparation and therapeutic use thereof | Jan 13, 2005 | Issued |
Array
(
[id] => 6912991
[patent_doc_number] => 20050176749
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/034635
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15428
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176749.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034635
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034635 | Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Jan 12, 2005 | Issued |
Array
(
[id] => 263923
[patent_doc_number] => 07569689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-08-04
[patent_title] => 'Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/034652
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16545
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/569/07569689.pdf
[firstpage_image] =>[orig_patent_app_number] => 11034652
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/034652 | Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Jan 12, 2005 | Issued |
Array
(
[id] => 225080
[patent_doc_number] => 07605264
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-10-20
[patent_title] => 'Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/035290
[patent_app_country] => US
[patent_app_date] => 2005-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/605/07605264.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035290
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035290 | Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof | Jan 12, 2005 | Issued |
Array
(
[id] => 9648848
[patent_doc_number] => 08802861
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-12
[patent_title] => 'Thiazole derivatives and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/585635
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48051
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10585635
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/585635 | Thiazole derivatives and use thereof | Jan 10, 2005 | Issued |
Array
(
[id] => 880584
[patent_doc_number] => 07355054
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-04-08
[patent_title] => 'Indole derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/032057
[patent_app_country] => US
[patent_app_date] => 2005-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7145
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/355/07355054.pdf
[firstpage_image] =>[orig_patent_app_number] => 11032057
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/032057 | Indole derivatives | Jan 10, 2005 | Issued |
Array
(
[id] => 6913034
[patent_doc_number] => 20050176792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Ketone substituted benzimidazole compounds'
[patent_app_type] => utility
[patent_app_number] => 11/035876
[patent_app_country] => US
[patent_app_date] => 2005-01-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7845
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176792.pdf
[firstpage_image] =>[orig_patent_app_number] => 11035876
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/035876 | Ketone substituted benzimidazole compounds | Jan 6, 2005 | Abandoned |
Array
(
[id] => 7173237
[patent_doc_number] => 20050203155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections'
[patent_app_type] => utility
[patent_app_number] => 11/030538
[patent_app_country] => US
[patent_app_date] => 2005-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12805
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203155.pdf
[firstpage_image] =>[orig_patent_app_number] => 11030538
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/030538 | Imidazole compounds and human cellular proteins casein kinase I alpha, delta and epsilon as targets for medical intervention against Hepatitis C Virus infections | Jan 4, 2005 | Abandoned |
Array
(
[id] => 637950
[patent_doc_number] => 07125905
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Pyrrole substituted 2-indolinone protein kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/028477
[patent_app_country] => US
[patent_app_date] => 2005-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 66237
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125905.pdf
[firstpage_image] =>[orig_patent_app_number] => 11028477
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/028477 | Pyrrole substituted 2-indolinone protein kinase inhibitors | Jan 3, 2005 | Issued |
Array
(
[id] => 112368
[patent_doc_number] => 07718808
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-18
[patent_title] => 'Thiazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/584633
[patent_app_country] => US
[patent_app_date] => 2004-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 136587
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/718/07718808.pdf
[firstpage_image] =>[orig_patent_app_number] => 10584633
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/584633 | Thiazole derivatives | Dec 23, 2004 | Issued |